[144] Gilead Sciences Inc SEC Filing
Form 144 filing for Gilead Sciences (GILD) shows an insider intends to sell 2,500 common shares through Morgan Stanley Smith Barney on 08/15/2025, with an aggregate market value of $296,325 and the shares listed for sale on NASDAQ. The filing identifies prior acquisitions of the shares as restricted stock granted on 03/10/2024 (1,200 shares) and 03/10/2023 (1,300 shares). The notice also lists sales by the same person during the past three months totaling 5,000 shares with aggregate cash proceeds of approximately $553,000. The filer signs a representation that they are not aware of undisclosed material adverse information about the issuer.
Deposito del Modulo 144 per Gilead Sciences (GILD) indica che un insider intende vendere 2.500 azioni ordinarie tramite Morgan Stanley Smith Barney il 15/08/2025, con un valore di mercato complessivo di 296.325 USD e le azioni quotate al NASDAQ. Il deposito riporta che le azioni sono state acquisite in precedenza come restricted stock il 10/03/2024 (1.200 azioni) e il 10/03/2023 (1.300 azioni). La comunicazione segnala inoltre vendite effettuate dalla stessa persona negli ultimi tre mesi per un totale di 5.000 azioni, con proventi in contanti aggregati di circa 553.000 USD. Il dichiarante firma una dichiarazione in cui afferma di non essere a conoscenza di informazioni materiali avverse non divulgate sull'emittente.
Presentaci贸n del Formulario 144 para Gilead Sciences (GILD) muestra que un insider tiene la intenci贸n de vender 2.500 acciones ordinarias a trav茅s de Morgan Stanley Smith Barney el 15/08/2025, con un valor de mercado agregado de 296.325 USD y las acciones listadas en NASDAQ. La presentaci贸n identifica adquisiciones previas de las acciones como restricted stock concedidas el 10/03/2024 (1.200 acciones) y el 10/03/2023 (1.300 acciones). El aviso tambi茅n enumera ventas de la misma persona durante los 煤ltimos tres meses por un total de 5.000 acciones, con ingresos en efectivo agregados de aproximadamente 553.000 USD. El declarante firma una declaraci贸n en la que certifica que no tiene conocimiento de informaci贸n adversa material no divulgada sobre el emisor.
Gilead Sciences(GILD) 甏�霠� Form 144 鞝滌稖鞐愲姅 雮措秬鞛愱皜 2025-08-15鞐� Morgan Stanley Smith Barney毳� 韱淀暣 氤错喌欤� 2,500欤茧ゼ 毵る弰頃� 鞚橅枼鞚� 鞛堨溂氅�, 齑� 鞁滉皜臧� 296,325雼煬鞚搓碃 頃措嫻 欤检嫕鞚� NASDAQ鞐� 靸侅灔霅橃柎 鞛堧嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖靹滊電� 頃措嫻 欤检嫕鞚� 2024-03-10(1,200欤�) 氚� 2023-03-10(1,300欤�)鞐� 歆�旮夒悳 鞝滍暅欤�(restricted stock)搿� 鞚挫爠鞐� 旆摑霅橃棃鞚岇潉 氇呾嫓頃╇媹雼�. 霕愴暅 斓滉芳 3臧滌洈 霃欖晥 霃欖澕鞚胳澊 齑� 5,000欤茧ゼ 毵り皝頃橃棳 齑� 順勱笀 靾橃澋鞚� 鞎� 553,000雼煬鞓�雼る姅 鞝愲弰 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖鞛愲姅 氚滍枆須岇偓鞐� 雽�頃� 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 鞎岅碃 鞛堨 鞎婌潓鞚� 歆勳垹靹滌棎 靹滊獏頃╇媹雼�.
D茅p么t du formulaire 144 pour Gilead Sciences (GILD) indique qu'un initi茅 pr茅voit de vendre 2 500 actions ordinaires via Morgan Stanley Smith Barney le 15/08/2025, pour une valeur marchande totale de 296 325 USD et que les actions sont cot茅es au NASDAQ. Le d茅p么t pr茅cise que les actions ont 茅t茅 acquises ant茅rieurement comme restricted stock le 10/03/2024 (1 200 actions) et le 10/03/2023 (1 300 actions). L'avis mentionne 茅galement des ventes par la m锚me personne au cours des trois derniers mois totalisant 5 000 actions, avec des produits en esp猫ces agr茅g茅s d'environ 553 000 USD. Le d茅clarant signe une repr茅sentation attestant qu'il n'a pas connaissance d'informations d茅favorables significatives non divulgu茅es concernant l'茅metteur.
Formular 144-Einreichung f眉r Gilead Sciences (GILD) zeigt, dass ein Insider beabsichtigt, am 15.08.2025 眉ber Morgan Stanley Smith Barney 2.500 Stammaktien zu verkaufen, mit einem aggregierten Marktwert von 296.325 USD und Notierung der Aktien an der NASDAQ. Die Einreichung gibt an, dass die Aktien zuvor als Restricted Stock am 10.03.2024 (1.200 Aktien) und am 10.03.2023 (1.300 Aktien) zugewiesen wurden. Die Mitteilung listet zudem Verk盲ufe derselben Person in den letzten drei Monaten in H枚he von insgesamt 5.000 Aktien mit kumulierten Barerl枚sen von rund 553.000 USD auf. Der Einreicher unterzeichnet eine Erkl盲rung, dass ihm keine nicht offen gelegten, wesentlichen nachteiligen Informationen 眉ber den Emittenten bekannt sind.
- Transparent disclosure of planned sale details including broker, date, share count, and aggregate market value.
- Acquisition history provided showing shares were received as restricted stock on 03/10/2023 and 03/10/2024.
- Recent transaction history disclosed showing 5,000 shares sold in the past three months with aggregate proceeds of approximately $553,000.
- Attestation included that the filer represents no knowledge of undisclosed material adverse information.
- Insider selling activity could be perceived negatively by some investors: 5,000 shares sold in the prior three months.
- Proposed additional sale of 2,500 shares (market value $296,325) scheduled for 08/15/2025.
Insights
TL;DR: Routine insider sale disclosure: planned sale of 2,500 shares and recent sales of 5,000 shares totaling roughly $553k.
The filing is a standard Rule 144 notice documenting a proposed sale of 2,500 common shares via Morgan Stanley Smith Barney on 08/15/2025 for an aggregate stated market value of $296,325. It confirms the lots were acquired as restricted stock on 03/10/2023 and 03/10/2024, and provides a complete recent transaction history showing 5,000 shares sold in the prior three months for about $553,000 in gross proceeds. For investors, this is a transparency disclosure of insider liquidity activity rather than a corporate-operational update.
TL;DR: Filing documents insider liquidity and includes the standard representation about material non-public information.
This Form 144 contains required broker, lot, and acquisition details and the signer鈥檚 attestation that they do not possess undisclosed material adverse information. The notice supports regulatory compliance for an insider sale and helps stakeholders track officer/director/affiliate share disposals. It does not include additional corporate governance actions or changes in control.
Deposito del Modulo 144 per Gilead Sciences (GILD) indica che un insider intende vendere 2.500 azioni ordinarie tramite Morgan Stanley Smith Barney il 15/08/2025, con un valore di mercato complessivo di 296.325 USD e le azioni quotate al NASDAQ. Il deposito riporta che le azioni sono state acquisite in precedenza come restricted stock il 10/03/2024 (1.200 azioni) e il 10/03/2023 (1.300 azioni). La comunicazione segnala inoltre vendite effettuate dalla stessa persona negli ultimi tre mesi per un totale di 5.000 azioni, con proventi in contanti aggregati di circa 553.000 USD. Il dichiarante firma una dichiarazione in cui afferma di non essere a conoscenza di informazioni materiali avverse non divulgate sull'emittente.
Presentaci贸n del Formulario 144 para Gilead Sciences (GILD) muestra que un insider tiene la intenci贸n de vender 2.500 acciones ordinarias a trav茅s de Morgan Stanley Smith Barney el 15/08/2025, con un valor de mercado agregado de 296.325 USD y las acciones listadas en NASDAQ. La presentaci贸n identifica adquisiciones previas de las acciones como restricted stock concedidas el 10/03/2024 (1.200 acciones) y el 10/03/2023 (1.300 acciones). El aviso tambi茅n enumera ventas de la misma persona durante los 煤ltimos tres meses por un total de 5.000 acciones, con ingresos en efectivo agregados de aproximadamente 553.000 USD. El declarante firma una declaraci贸n en la que certifica que no tiene conocimiento de informaci贸n adversa material no divulgada sobre el emisor.
Gilead Sciences(GILD) 甏�霠� Form 144 鞝滌稖鞐愲姅 雮措秬鞛愱皜 2025-08-15鞐� Morgan Stanley Smith Barney毳� 韱淀暣 氤错喌欤� 2,500欤茧ゼ 毵る弰頃� 鞚橅枼鞚� 鞛堨溂氅�, 齑� 鞁滉皜臧� 296,325雼煬鞚搓碃 頃措嫻 欤检嫕鞚� NASDAQ鞐� 靸侅灔霅橃柎 鞛堧嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖靹滊電� 頃措嫻 欤检嫕鞚� 2024-03-10(1,200欤�) 氚� 2023-03-10(1,300欤�)鞐� 歆�旮夒悳 鞝滍暅欤�(restricted stock)搿� 鞚挫爠鞐� 旆摑霅橃棃鞚岇潉 氇呾嫓頃╇媹雼�. 霕愴暅 斓滉芳 3臧滌洈 霃欖晥 霃欖澕鞚胳澊 齑� 5,000欤茧ゼ 毵り皝頃橃棳 齑� 順勱笀 靾橃澋鞚� 鞎� 553,000雼煬鞓�雼る姅 鞝愲弰 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖鞛愲姅 氚滍枆須岇偓鞐� 雽�頃� 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 鞎岅碃 鞛堨 鞎婌潓鞚� 歆勳垹靹滌棎 靹滊獏頃╇媹雼�.
D茅p么t du formulaire 144 pour Gilead Sciences (GILD) indique qu'un initi茅 pr茅voit de vendre 2 500 actions ordinaires via Morgan Stanley Smith Barney le 15/08/2025, pour une valeur marchande totale de 296 325 USD et que les actions sont cot茅es au NASDAQ. Le d茅p么t pr茅cise que les actions ont 茅t茅 acquises ant茅rieurement comme restricted stock le 10/03/2024 (1 200 actions) et le 10/03/2023 (1 300 actions). L'avis mentionne 茅galement des ventes par la m锚me personne au cours des trois derniers mois totalisant 5 000 actions, avec des produits en esp猫ces agr茅g茅s d'environ 553 000 USD. Le d茅clarant signe une repr茅sentation attestant qu'il n'a pas connaissance d'informations d茅favorables significatives non divulgu茅es concernant l'茅metteur.
Formular 144-Einreichung f眉r Gilead Sciences (GILD) zeigt, dass ein Insider beabsichtigt, am 15.08.2025 眉ber Morgan Stanley Smith Barney 2.500 Stammaktien zu verkaufen, mit einem aggregierten Marktwert von 296.325 USD und Notierung der Aktien an der NASDAQ. Die Einreichung gibt an, dass die Aktien zuvor als Restricted Stock am 10.03.2024 (1.200 Aktien) und am 10.03.2023 (1.300 Aktien) zugewiesen wurden. Die Mitteilung listet zudem Verk盲ufe derselben Person in den letzten drei Monaten in H枚he von insgesamt 5.000 Aktien mit kumulierten Barerl枚sen von rund 553.000 USD auf. Der Einreicher unterzeichnet eine Erkl盲rung, dass ihm keine nicht offen gelegten, wesentlichen nachteiligen Informationen 眉ber den Emittenten bekannt sind.
FAQ
What does the Form 144 for GILD disclose about planned sales?
How many shares did the insider sell in the past three months and for how much?
When were the shares to be sold originally acquired?
Through which broker will the proposed sale be executed?
Does the filer make any representation about material non-public information?
